Welcome!
I-MAB
Medtech
GIC joins consortium to invest US$418 mil in biopharmaceutical company I-MAB
According to GIC, I-MAB will receive all proceeds from the private placement and intends to utilize them to fund its ongoing and planned research and clinical programmes.
September 04, 2020